About RizLab Health
RizLab Health is a Healthcare company based in Princeton (United States) founded in 2018 by Shahriar Azizpour and Mehdi Javanmard. An AI-based device for complete blood count analysis is developed. RizLab Health has raised $250 thousand across 2 funding rounds from investors including IndieBio and America’s Seed Fund. Its chief executive, as recorded, is Mehdi Javanmard. RizLab Health offers products and services including CytoTracker. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Blood Analyzer. Its legal entity is RizLab Health, Inc. Its competitors include Daxor, Cellmic and Essenlix; 2 of its 3 listed competitors have raised funding.
Company details
RizLab Health was founded in 2018 in Princeton, United States, within the health technology sector. An AI-based device known as the CBC Analyzer is developed, incorporating disposable plug-and-play cartridges and reusable readout units for complete blood count analysis. Operations focus on medical diagnostics through artificial intelligence, serving healthcare needs in laboratory and point-of-care settings.
- Headquarters Princeton, United States
- Founders Shahriar Azizpour, Mehdi Javanmard
- SectorsHealthcare
- Website rizlabhealth.com
- Social LinkedIn X
- Legal Name Rizlab Health, Inc.
- Total Equity Funding$250K (USD)
in 2 rounds
- Latest Funding Round$250K (USD), Seed
Oct 2021
- InvestorsIndieBio
& 1 more
Products & Services of RizLab Health
RizLab Health offers a comprehensive portfolio of products and services, including CytoTracker.
Pocket-sized device for rapid white blood cell counting and diagnostics.
Funding Insights of RizLab Health
RizLab Health has successfully raised a total of $250K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $250,000
- Total Rounds 2
- Last Round Seed — $250,000
- First Round $256,000
(Sep 2020)
- Investors Count 2
All 2 funding rounds of RizLab Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $250,000 | Seed | – | IndieBio | – |
| Sep 2020 | $256,000 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in RizLab Health
RizLab Health has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include IndieBio and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | indiebio.co | San Francisco, United States | ||
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States |
Investor details for RizLab Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RizLab Health
4 people are tracked at RizLab Health (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Shahriar Azizpour | Co-Founder | Leadership |
Mehdi Javanmard | Co-Founder & CEO | Leadership |
Ruba Sarris Sawaya | Chief Commercialization Officer (fractional) | Leadership |
Mark Follman | PD + Commercialization Consultant | Team |
Complete people profiles for RizLab Health
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RizLab Health
3 dated milestones of RizLab Health across 3 years, from founding to its latest funding, stage changes and deals.
- Founded RizLab Health is founded.
- Funding First funding round of $256K.
- Funding Latest funding round, Seed, of $250K.
Competitors of RizLab Health
RizLab Health has 3 listed competitors in our database, 2 of them funded. They include Daxor, Cellmic and Essenlix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| daxor.com | 1970 | New York, United States | 22 | Blood volume analyzers are developed by Daxor for diagnostic applications. | ||
| cellmic.com | 2009 | Los Angeles, United States | $5M | Rapid test readers are developed for chromatographic and fluorescent assays. | ||
| essenlix.com | 2013 | Monmouth Junction, United States | $20M | Mobile health self-test platform is provided using nanotechnology and AI. |
Detailed competitors of RizLab Health
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
3 companies that operate in the same segment as RizLab Health (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RizLab Health
RizLab Health was founded in 2018 and raised its 1st funding round 2 years after it was founded.
RizLab Health is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Mehdi Javanmard is the CEO of RizLab Health, as recorded in our data. They have also founded this company.
RizLab Health is a funded company, having raised a total of $250K across 2 funding rounds to date. The company's 1st funding round was a Grant of $256K, raised on Sep 2020.
RizLab Health was founded in 2018 in Princeton, United States, within the health technology sector. An AI-based device known as the CBC Analyzer is developed, incorporating disposable plug-and-play cartridges and reusable readout units for complete blood count analysis. Operations focus on medical diagnostics through artificial intelligence, serving healthcare needs in laboratory and point-of-care settings.
RizLab Health offers CytoTracker.
RizLab Health has 2 investors. Key investors include IndieBio, and America’s Seed Fund.
RizLab Health operates through Rizlab Health, Inc..